FIELD: medicine.
SUBSTANCE: invention refers to biotechnology and immunology. What is described is a method for producing a preparation of an antibody or its antigen-binding portion with a lower content of host cell protein (HCP). The method provides reducing a pH value to approximately 3.8 in the sample by adding citric or phosphoric acid, reducing the pH value to 5.0, applying the sample onto ion-exchange resin, collecting the sample after the ion exchange, applying the sample onto resin for performing a hydrophobic-interaction chromatography and collecting a post-chromatography antibody preparation. The invention can be used in medicine.
EFFECT: method enables producing the antibody preparation, which contains the reduced viral particle count and possesses the reduced viral activity.
22 cl, 5 dwg, 11 tbl
Title | Year | Author | Number |
---|---|---|---|
SEPARATION AND PURIFICATION OF ANTIBODIES WITH APPLICATION OF PROTEIN A-BASED AFFINITY CHROMATOGRAPHY | 2009 |
|
RU2520838C2 |
ISOLATION AND PURIFICATION OF ANTI-IL-13 ANTIBODIES USING PROTEIN A AFFINITY CHROMATOGRAPHY | 2010 |
|
RU2603055C2 |
METHOD OF OBTAINING PREPARATION OF ANTIBODY AGAINST IL-18 OR ITS ANTIGEN-BINDING PART (VERSIONS) | 2009 |
|
RU2514657C2 |
ANTIBODIES TO INTERLEUKIN-1ALPHA, AND APPLICATION METHODS THEREOF | 2013 |
|
RU2666915C2 |
ANTIBODIES TO INTERLEUKIN-1α, AND ITS APPLICATION METHODS | 2009 |
|
RU2498998C2 |
METHODS AND COMPOSITIONS INCLUDING PURIFIED RECOMBINANT POLYPEPTIDES | 2014 |
|
RU2793783C1 |
METHODS AND COMPOSITIONS COMPRISING PURIFIED RECOMBINANT POLYPEPTIDES | 2014 |
|
RU2671481C2 |
TRISPECIFIC IL-17A, IL-17F AND OTHER PROINFLAMMATORY MOLECULES ANTIBODIES | 2016 |
|
RU2680011C2 |
USE OF LECTINS FOR GLYCOPROTEIDS AND ANTIGENIC MOLECULES OLIGOMERISATION ACTIVATION | 2004 |
|
RU2399381C2 |
IL-13 RECEPTOR ALPHA 1 ANTIBODIES AND THEIR APPLICATION | 2006 |
|
RU2413736C2 |
Authors
Dates
2015-05-20—Published
2009-10-20—Filed